Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours

Pathology

Volumn 36, Issue 5, 2004, Pages 478-484

  Cochran, Alistair J ^a   Roberts, Alice ^a   Wen, Duan Ren ^a   Huang, Rong Rong ^a   Itakura, Eijun ^a   Luo, Frank ^a   Binder, Scott W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Melanoma; Micrometastases; Microscopy; Molecular biology; Prognosis; Sentinel nodes

Indexed keywords

CARBON; DYE; EOSIN; HEMATOXYLIN;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CELL POPULATION; DENDRITIC CELL; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MELANOMA; MICROSCOPY; MOLECULAR BIOLOGY; PATHOLOGIST; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; SAMPLING; SENTINEL LYMPH NODE BIOPSY; STAINING; TISSUE SECTION; TREATMENT INDICATION; WORKLOAD;

EID: 4344657608     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020412331282726     Document Type: Article

References (30)

1. Cochran AJ, Roberts A, Wen D-R, et al. Optimized assessment of sentinel lymph nodes for metastatic melanoma: Implications for regional surgery and overall treatment planning. Ann Surg Oncol 2004;11 (3 Suppl): 1565-615.
2. Lucci A, Turner RR, Morton DL. Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection. Surgery 1999; 126: 48-53.
3. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel nodes in cutaneous melanoma. Cancer 2001; 92: 535-41.
4. Morton DL, Hoon DSB, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238: 538-49.
5. Cochran AJ, Pihl E, Wen D-R, et al. Zoned immune suppression of lymph nodes draining malignant melanoma: Histologic and immunohistologic studies. J Natl Cancer Inst 1987; 78: 399-405.
6. Huang RR, Wen DR, Guo J, et al. Selective modulation of paracortical dendritic cells and T lymphocytes in breast cancer sentinel lymph nodes. Breast J 2000; 6: 225-32.
7. Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: Implications for tumor biology and treatment. Mod Pathol 2001; 14: 604-8.
8. Lana A-M, Wen D-R, Cochran AJ. The morphology, immunophenotype and distribution of paracortical dendritic leukocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res 2001; 11: 1-10.
9. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
10. Cochran AJ, Roberts AA, Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 2003; 8: 139-50.
11. Cochran AJ. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 1999; 23: 1169-72.
12. Singletary SE, Byers RM, Shallenberger R, et al. Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. Am J Surg 1986; 152: 371-5.
13. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91: 2110-21.
14. Cochran AJ, Lana AMA, Wen D-R. Histomorphometry in the assessment of prognosis in Stage II melanoma. Am J Surg Pathol 1989; 13: 600-4.
15. Cochran AJ, Morton DL, Johnson TD, et al. Prediction of outcome and tumor-status of the non-sentinel node in melanoma patients with a positive sentinel node. Mod Pathol 2000; 13: 61 (Abstr).
16. Carson KF, Wen D-R, Li P-X, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996; 20: 834-40.
17. Cochran AJ. The pathologist's role in sentinel lymph node evaluation. Semin Nucl Med 2000; 30: 11-7.
18. Cochran AJ. Sentinel lymph node pathology. Progress in Pathology 2001; 5: 45-56.
19. Cochran AJ, Roberts AA, Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 2003; 8: 139-50.
20. Wen D-R, Huang R-R, Binder S, Morton DL, Cochran AJ. Evaluation of melanoma in non-sentinel nodes: How much is enough? Mod Pathol 2004; 17 (Suppl 1): 100A.
21. Cochran AJ, Wen D-R, Huang R-R, et al. Prediction of metastatic melanoma in non-sentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004; 17: 747-55.
22. Wen D-R, Huang R-R, Starz H, et al. Prognostic factors predict non-sentinel node status in melanoma patients. Mod Pathol 2003; 16: 101A.
23. Kelley SW, Cockerell CJ. Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: a proposal. J Am Acad Dermatol 2000; 42: 527-30.
24. Zuckerman R, Maier JP, Guiney WB Jr, Huntsman WT, Mooney EK. Pediatric melanoma: confirming the diagnosis with sentinel node biopsy. Ann Plast Surg 2001; 46: 394-9.
25. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002; 26: 47-55.
26. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 2003; 97: 499-507.
27. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003; 200: 314-9.
28. Starz H, Haas CJ, Schulz GM, Balda BR. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes. Mod Pathol 2003; 16: 920-9.
29. Wagner JD, Davidson D, Coleman JJ 3rd, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999; 6: 398-04.
30. Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002; 9: 975-81.